Nuclear alternate estrogen receptor GPR30 mediates 17beta-estradiol-induced gene expression and migration in breast cancer-associated fibroblasts
about
GPER Function in Breast Cancer: An OverviewG-protein coupled receptor 30 (GPR30): a novel regulator of endothelial inflammationThe G-protein-coupled estrogen receptor GPER in health and diseaseGPER signalling in both cancer-associated fibroblasts and breast cancer cells mediates a feedforward IL1β/IL1R1 response.GPER is involved in the stimulatory effects of aldosterone in breast cancer cells and breast tumor-derived endothelial cellsEstrogen biology: new insights into GPER function and clinical opportunitiesThe role of cadmium and nickel in estrogen receptor signaling and breast cancer: metalloestrogens or not?Effects of atrazine on estrogen receptor α- and G protein-coupled receptor 30-mediated signaling and proliferation in cancer cells and cancer-associated fibroblastsCopper activates HIF-1α/GPER/VEGF signalling in cancer cellsGPCRs and cancerAlternate estrogen receptors promote invasion of inflammatory breast cancer cells via non-genomic signalingMIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells.Low ERK phosphorylation in cancer-associated fibroblasts is associated with tamoxifen resistance in pre-menopausal breast cancer.Targeting GPR30 with G-1: a new therapeutic target for castration-resistant prostate cancer.G protein-coupled estrogen receptor regulates mammary tumorigenesis and metastasisThe G protein-coupled receptor 30 is up-regulated by hypoxia-inducible factor-1alpha (HIF-1alpha) in breast cancer cells and cardiomyocytesGPER mediates cardiotropic effects in spontaneously hypertensive rat hearts.Estrogen protection in Friedreich's ataxia skin fibroblasts.Estrogen action and prostate cancer.Novel Aspects Concerning the Functional Cross-Talk between the Insulin/IGF-I System and Estrogen Signaling in Cancer Cells.International Union of Basic and Clinical Pharmacology. XCVII. G Protein-Coupled Estrogen Receptor and Its Pharmacologic ModulatorsEstrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER.Estrogen- and xenoestrogen-induced ERK signaling in pituitary tumor cells involves estrogen receptor-α interactions with G protein-αi and caveolin I.Dehydroepiandrosterone Activation of G-protein-coupled Estrogen Receptor Rapidly Stimulates MicroRNA-21 Transcription in Human Hepatocellular Carcinoma CellsmiRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets.The effects of (-)-epicatechin on endothelial cells involve the G protein-coupled estrogen receptor (GPER).Estrogens Suppress Spinal Endomorphin 2 Release in Female Rats in Phase with the Estrous Cycle.A calixpyrrole derivative acts as an antagonist to GPER, a G-protein coupled receptor: mechanisms and models.Bisphenol A induces gene expression changes and proliferative effects through GPER in breast cancer cells and cancer-associated fibroblasts.Expression of the G protein-coupled estrogen receptor (GPER) in endometriosis: a tissue microarray study.SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.Macromolecular Modelling and Docking Simulations for the Discovery of Selective GPER Ligands.G protein-coupled estrogen receptor mediates the up-regulation of fatty acid synthase induced by 17β-estradiol in cancer cells and cancer-associated fibroblasts.Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress.Recent Advances on the Role of G Protein-Coupled Receptors in Hypoxia-Mediated Signaling.G protein-coupled estrogen receptor-selective ligands modulate endometrial tumor growthThe G protein-coupled estrogen receptor (GPER) is expressed in two different subcellular localizations reflecting distinct tumor properties in breast cancerEstrogen-induced SDF-1α production promotes the progression of ER-negative breast cancer via the accumulation of MDSCs in the tumor microenvironment.The G-protein-coupled estrogen receptor agonist G-1 suppresses proliferation of ovarian cancer cells by blocking tubulin polymerization.GPER-mediated proliferation and estradiol production in breast cancer-associated fibroblasts.
P2860
Q21131274-3A84AE53-667C-4A2B-B19E-192F833AD5CEQ24307603-9902D68F-B291-4F44-A645-61DB563790E5Q27013052-E8D39349-F4F1-44C5-B2A4-900E3A2661B8Q27322202-47EDCE7D-ED45-45B1-AB6A-C78FD511B1E2Q27340035-7051CA60-3C9B-42F1-B73B-E7740896DB01Q28307726-84BE1A97-8539-42B1-B155-93380897D140Q28390036-AEEFE5BC-1964-4CDF-9F41-4B65B18F71EFQ28393409-44A31658-55C1-4528-9A32-3132C40BBBB4Q28601324-CEE111D7-FE05-44B8-BB50-E8DA5BE3389DQ33828719-86D46A1F-8247-46DF-A1CE-E4CF73140098Q34147662-5A95A010-E32E-4FC9-8A57-4D6A78DD0ECBQ34247686-93A052B9-C91C-45C7-8865-9F5B80597198Q34429766-D9152D8C-0EE0-4953-903C-C6E9A3B6D526Q34518031-27AF82A5-DF60-45EC-BD5B-5C8F3CC193CBQ34518541-22366CA8-9793-44DB-BCE2-651F42AAEAA7Q34696040-F00E63A7-A683-4FAD-A7B1-8E40F730E2DDQ34946257-D677CAEC-13B0-4B72-B867-7BF7DA332485Q35046921-B5E6EF99-00C7-42FE-94AE-9E82845DCD7FQ35099011-CCFD4A98-6C20-48CD-928C-DB39821A1E1EQ35153546-2E6FEA0D-12D0-4C25-BDA3-70CB30700CBBQ35795751-16073B10-FB40-47B9-A5FC-687DDCE6BD02Q35809173-B152035F-D566-4F2D-824D-E7B6B39F6783Q35831036-00CB5AEA-C097-4643-9925-B9D45374E17EQ35860722-AAC387FF-E430-4CBF-A074-29668E617F57Q35912303-3D9AC593-FB78-4614-8B4E-90C98DDCFBE5Q36014772-BD49DD86-4198-4446-8E61-3BFB78072424Q36074349-757354C8-E7EE-4CE7-AC7B-BE830B65B277Q36175376-07879CA1-2374-4080-A9FA-29523C3004E4Q36229070-AB66A30B-E544-4D5F-AB94-E616FE43604AQ36235904-33D9994B-A91A-45BF-B61F-91B77DDD4AA5Q36293908-DB60D937-8B7E-4B18-9C1F-0F0C6622E533Q36445127-1BD13F38-A4DF-4CF8-9CE4-5D0D995BBACFQ36481702-13105AC6-2C59-403A-AC78-A65CDEFBC7F4Q36618752-306451C6-9BAF-4434-BBB6-4D1EC1C433ABQ36653897-14C14FEE-A5DF-4693-AC1B-7A71B2F6A76AQ37393019-4429FC33-A261-4FD7-B925-56101E7967F7Q37451956-DC1B935E-F162-4909-975B-B463E08DE123Q37519342-6636BA4D-F790-452A-982E-15AA9C5190BFQ37577483-62587861-BE8B-4B08-AB67-6939230B5D26Q37648861-5B7FDC8F-0C86-476A-A51B-AC9838ACD6B2
P2860
Nuclear alternate estrogen receptor GPR30 mediates 17beta-estradiol-induced gene expression and migration in breast cancer-associated fibroblasts
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Nuclear alternate estrogen rec ...... cancer-associated fibroblasts
@ast
Nuclear alternate estrogen rec ...... cancer-associated fibroblasts
@en
Nuclear alternate estrogen rec ...... cancer-associated fibroblasts
@en-gb
Nuclear alternate estrogen rec ...... cancer-associated fibroblasts
@nl
type
label
Nuclear alternate estrogen rec ...... cancer-associated fibroblasts
@ast
Nuclear alternate estrogen rec ...... cancer-associated fibroblasts
@en
Nuclear alternate estrogen rec ...... cancer-associated fibroblasts
@en-gb
Nuclear alternate estrogen rec ...... cancer-associated fibroblasts
@nl
prefLabel
Nuclear alternate estrogen rec ...... cancer-associated fibroblasts
@ast
Nuclear alternate estrogen rec ...... cancer-associated fibroblasts
@en
Nuclear alternate estrogen rec ...... cancer-associated fibroblasts
@en-gb
Nuclear alternate estrogen rec ...... cancer-associated fibroblasts
@nl
P921
P3181
P1433
P1476
Nuclear alternate estrogen rec ...... cancer-associated fibroblasts
@en
P2093
Antonio Madeo
P304
P3181
P356
10.1158/0008-5472.CAN-10-0408
P407
P577
2010-07-15T00:00:00Z